Volume 52, Issue 6, Pages (December 2013)

Slides:



Advertisements
Similar presentations
Volume 103, Issue 1, Pages (September 2000)
Advertisements

Volume 14, Issue 1, Pages (January 2014)
Bryan K. Sun, Aimée M. Deaton, Jeannie T. Lee  Molecular Cell 
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors  Kazutoshi Takahashi, Shinya Yamanaka  Cell 
Volume 9, Issue 5, Pages (November 2017)
Volume 20, Issue 13, Pages (September 2017)
Volume 11, Issue 8, Pages (May 2015)
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Volume 17, Issue 6, Pages (December 2015)
Volume 47, Issue 2, Pages (July 2012)
Volume 3, Issue 4, Pages (October 2008)
Volume 56, Issue 1, Pages (October 2014)
Volume 11, Issue 2, Pages (August 2012)
Volume 12, Issue 3, Pages (March 2013)
Volume 43, Issue 3, Pages e6 (November 2017)
Volume 4, Issue 2, Pages (February 2015)
Volume 29, Issue 4, Pages (May 2014)
Volume 11, Issue 6, Pages (December 2012)
Volume 13, Issue 6, Pages (December 2013)
Volume 23, Issue 2, Pages (April 2018)
Volume 17, Issue 4, Pages (October 2015)
Volume 13, Issue 1, Pages (July 2013)
Volume 22, Issue 4, Pages (January 2018)
Volume 2, Issue 2, Pages (February 2008)
Volume 2, Issue 6, Pages (June 2014)
Volume 6, Issue 1, Pages (January 2016)
Volume 9, Issue 5, Pages (November 2017)
Volume 5, Issue 3, Pages (September 2015)
Volume 53, Issue 6, Pages (March 2014)
Wnt Signaling Promotes Reprogramming of Somatic Cells to Pluripotency
Volume 16, Issue 3, Pages (March 2015)
Volume 13, Issue 1, Pages (July 2013)
Volume 21, Issue 6, Pages (December 2011)
X Chromosome Inactivation Is Mediated by Xist RNA Stabilization
Volume 46, Issue 1, Pages (April 2012)
Early Lineage Segregation between Epiblast and Primitive Endoderm in Mouse Blastocysts through the Grb2-MAPK Pathway  Claire Chazaud, Yojiro Yamanaka,
Volume 3, Issue 5, Pages (November 2008)
Jamie A. Hackett, Toshihiro Kobayashi, Sabine Dietmann, M. Azim Surani 
Volume 25, Issue 13, Pages e5 (December 2018)
Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts
Volume 9, Issue 4, Pages (October 2017)
Volume 3, Issue 5, Pages (November 2008)
Volume 25, Issue 6, Pages (June 2013)
Volume 27, Issue 5, Pages (December 2013)
Volume 13, Issue 1, Pages (October 2015)
Devendra S. Mistry, Yifang Chen, George L. Sen  Cell Stem Cell 
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Volume 10, Issue 1, Pages (January 2018)
Volume 55, Issue 5, Pages (September 2014)
Volume 55, Issue 5, Pages (September 2014)
Drosophila Maelstrom Ensures Proper Germline Stem Cell Lineage Differentiation by Repressing microRNA-7  Jun Wei Pek, Ai Khim Lim, Toshie Kai  Developmental.
Volume 7, Issue 2, Pages (August 2010)
Volume 3, Issue 3, Pages (September 2008)
Volume 21, Issue 13, Pages (December 2017)
Volume 5, Issue 6, Pages (December 2015)
Volume 32, Issue 2, Pages (October 2008)
Volume 52, Issue 6, Pages (December 2013)
Short Telomeres in ESCs Lead to Unstable Differentiation
Volume 1, Issue 3, Pages (September 2007)
Volume 7, Issue 2, Pages (August 2016)
Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling
CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State
Volume 9, Issue 5, Pages (November 2017)
Volume 17, Issue 3, Pages (October 2016)
Masakazu Hashimoto, Hiroshi Sasaki
Volume 64, Issue 5, Pages (December 2016)
Volume 3, Issue 3, Pages (March 2013)
Oct4: The Final Frontier, Differentiation Defining Pluripotency
Nanog-Independent Reprogramming to iPSCs with Canonical Factors
Volume 22, Issue 6, Pages e6 (June 2018)
Presentation transcript:

Volume 52, Issue 6, Pages 805-818 (December 2013) Tsix RNA and the Germline Factor, PRDM14, Link X Reactivation and Stem Cell Reprogramming  Bernhard Payer, Michael Rosenberg, Masashi Yamaji, Yukihiro Yabuta, Michiyo Koyanagi-Aoi, Katsuhiko Hayashi, Shinya Yamanaka, Mitinori Saitou, Jeannie T. Lee  Molecular Cell  Volume 52, Issue 6, Pages 805-818 (December 2013) DOI: 10.1016/j.molcel.2013.10.023 Copyright © 2013 Elsevier Inc. Terms and Conditions

Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 XCR Assayed by H3K27me3 Staining in Blastocysts (A–E) Shown are z series projections of E3.5 wild-type (A), E4.5 wild-type (B), E4.5 Prdm14−/− (C), E4.5 Tsix−/− (D), and E4.5 double-mutant (E) female blastocysts immunostained for H3K27me3 (green) and the lineage markers NANOG (red) and GATA4 (blue). Cell lineage territories are outlined in (E). (Epiblast [Epi], NANOG+ within ICM; primitive endoderm [PE], GATA4+; trophectoderm (TE), rest). Middle and right panels show close-ups of the ICM (white boxes). Arrows, Xi in NANOG+ cells. NANOG+ cells outside the ICM never undergo XCR (stars). Scale bars = 20 μm. See also Figure S1. Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Quantification of XCR in Prdm14 and Tsix Mutant Blastocysts (A–C) XCR in Prdm14 (A), Tsix (B), and double-mutant (C) E4.5 blastocysts was scored as the percent of NANOG+ epiblast cells without H3K27me3 foci per embryo. Every data point on the scatter plots represents reactivation efficiency plotted against total number of cells per embryo indicating developmental progression. Trend lines (A and B) follow logarithmic regression. The box plots summarize the data, with boxes demarcating the 25th–75th percentile (only shown if n > 3), the median indicated by dotted lines, and the mean indicated by solid lines. Whiskers extend to minimum and maximum values. Statistical significances have been calculated using one-way ANOVA (∗∗p < 0.01). Note: for genotypes, maternal allele is represented first by convention. In (B), black dashed lines separate delayed embryos with low cell number (≤80 cells) from advanced embryos (>80 cells). All embryos including Prdm14/Tsix double mutants are shown in (C). The highlighted areas encompass Prdm14+/+ (black) or Prdm14−/− (red) embryos of all Tsix genotypes. Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Prdm14−/− Embryos Show Normal Cell Fates and Mendelian Ratios during Preimplantation Stages, but Abnormal Postimplantation Development (A and B) Analysis of cell lineage distribution in E4.5 blastocysts from Prdm14+/− intercrosses (2 litters, 11 embryos) by immunostaining (A) for the cell lineage markers NANOG (cyan; Epi), GATA4 (red; PE), and CDX2 (green; TE). Scale bar = 20 μm. Counts in (B) are given as the percent of cells of each lineage per total blastocyst cell number (error bars = SEM). (C) Genotype distribution of embryos and pups from Prdm14+/− heterozygous intercrosses. The right column represents the expected Mendelian ratio. Resorptions were not genotyped due to lack of embryonic material. n = number of embryos. (D and E) Sex and genotype distribution from Prdm14+/− heterozygous intercrosses (16 litters, 75 pups) (D) and Prdm14+/− Tsix−/− female with Prdm14+/− Tsix− male intercrosses (14 litters, 49 pups) (E). (F and G) Examples for abnormal Prdm14−/− E10.5 (F) and E12.5 (G) embryos compared to wild-type littermates. The resorption in (G) consists of decidual tissue with no apparent embryonic material. Scale bars = 1 mm. Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Prdm14 Is Important for Self-Renewal of iPSCs (A and B) Primary iPSC colonies of different Prdm14 (A) and Tsix and Prdm14 (B) genotypes. Reprogramming efficiency was scored as the percent of primary colonies formed per input TTFs after 10 days of Dox induction. Each graph depicts data from one experiment performed in triplicate (error bars = SEM). (C) AP stainings of replated iPSC colonies. A total of 1,000 primary iPSCs for each genotype have been reseeded and grown for 14 days without Dox (independent of viral four-factor expression). (D) Quantification of AP-positive replated colonies of different Prdm14 genotypes. Primary iPSCs (100, 500, or 1,000) were seeded and grown without Dox for 7 days. (E) Quantification of AP-positive replated colonies of different Prdm14 and Tsix genotypes grown from 1,000 primary iPSCs without Dox for 11 days. Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 The Self-Renewal Defect of Prdm14−/− iPSCs Is Partially Rescued by Maintained Exogenous Pluripotency Factor Expression or by Derivation and Culture in 2i + LIF. (A and B) Replating efficiency of iPSCs depending on exogenous pluripotency factor expression. Primary iPSCs were derived in 11 days with Dox before reseeding and culture for 14 days with (+Dox) or without (−Dox) induction of the lentiviral reprogramming cassette. Replating efficiency was measured as AP-positive colonies per seeded input iPSCs (A). ∗p < 0.05, ∗∗p < 0.01 two-way ANOVA with Bonferroni posttest was used to compare individual means. In (B), the relative colony number increase of continuous Dox treatment over Dox withdrawal is shown. Error bars = SEM. (C and D) Quanititative PCR (qPCR) measurements of gene expression in Prdm14+/+ (black) and Prdm14−/− (red) iPSCs cultured with (+Dox) or without (−Dox) exogenous OKSM factors. (C) Endogenous pluripotency gene expression. ∗p = 0.034 two-tailed Student’s t test. (D) Gata6 (endodermal differentiation marker) and de novo DNA methyltransferase expression. ∗∗p = 0.00097. Error bars = SEM. (E) Relative number of NANOG+ colonies from Prdm14−/− cells (red) compared to Prdm14+/+ reprogrammed under FBS + LIF conditions (black, set to 100%). ∗∗p = 0.008 two-tailed Student’s t test. (F) NANOG activation and silencing of retroviral vectors (DsRed-negative) in iPSC colonies were used as indicators of successful reprogramming in FBS + LIF conditions (Hoechst = DNA). Error bars = SEM. (G) Comparison of derivation efficiency of Prdm14+/+ versus Prdm14−/− iPSCs in 2i + LIF conditions. (H) NANOG activation and DsRed silencing in iPSCs derived in 2i + LIF. Scale bar = 4 mm. Error bars = SEM. Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 XCR during iPSC Reprogramming Is Perturbed in Prdm14−/−, But Not in Tsix−/−, Cells (A) Percent iPSC colonies of different Tsix genotypes with XGFP-reactivation during reprogramming (10 days +Dox). (B) Tsix+/+ and Tsix−/− iPSC colonies showing complete XGFP-reactivation during Dox-independent culture after replating (7 days −Dox). Scale bar = 100 μm. (C) RNA immunoFISH of fibroblasts and iPSCs during reprogramming (8 days +Dox). Some NANOG/SSEA1 (pluripotent stem cell markers) double-positive cells have downregulated Xist (stars), while others (yellow arrows) still show Xist expression similar to NANOG-negative cells (white arrowheads), which were consistently Xist positive. Scale bar = 10 μm. (D–F) Xist RNA-FISH of NANOG-positive iPSCs of different Tsix (10 days with Dox, 1 day without Dox) (D), Prdm14 (10 days with Dox) (E), or Prdm14/Tsix (8 days with Dox) genotypes (F). ∗p = 0.0463 two-tailed Fisher’s exact test. Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 PRDM14 Promotes XCR by Repressing the Xist Activator Rnf12 and through Tsix-Dependent Binding to Xist Intron 1 (A) Expression analysis of X-inactivation regulator genes at the Xic by qPCR in undifferentiated Prdm14+/+ and Prdm14−/− ESCs. Expression levels are normalized by Gapdh relative to Prdm14+/+ cells (set to 100%). ∗∗p = 0.0026 two-tailed Student’s t test. Error bars = SEM. (B) ChIP-seq data for binding of NANOG, OCT4, SOX2 (Marson et al., 2008), and PRDM14 (Ma et al., 2011) along the Xic, retrieved via the NCBI epigenomics database (http://www.ncbi.nlm.nih.gov/epigenomics). Arrows indicate cobound pluripotency factor binding sites 5 kb (a), 4 kb (b), or immediately (c) upstream of Rnf12 and in Xist intron 1 (d). See also Figure S2. (C) ChIP-seq analysis of the Rnf12 locus. PRDM14 binding (blue) and comparison of SUZ12 and H3K27me3 occupancy between Prdm14+/+ (black) and Prdm14−/− (red) ESCs (Yamaji et al., 2013). (D) ChIP-qPCR with hemagglutinin (HA)-tagged PRDM14 expressed in undifferentiated ESCs at the Rnf12 promoter (∗∗∗p = 0.0008). Control = nontransfected ESCs. Error bars in (D), (E), (G), and (H) = SD. (E) ChIP-qPCR for H3K27me3 upstream of Rnf12 in Prdm14+/+ and −/− ESCs. (∗∗p = 0.002). (F) ChIP-seq analysis of the Xist locus (as in B). (G) ChIP-qPCR with PRDM14-HA at Xist intron 1 (as in C). ∗∗∗p = 0.0009. (H) Mus/Cas allelic binding ratio of PRDM14-HA in undifferentiated hybrid Tsix−/+ (blue; Mus = Tsix−, Cas = Tsix+) and Tsix+/+ (black) ESCs (∗∗p = 0.0013). (I) Model for the roles of PRDM14 and Tsix during XCR. In differentiated cells and before XCR (left), PRDM14 and Tsix are absent, while RNF12 and Jpx RNA activate Xist, leading to XCI. During XCR in pluripotent stem cells and during embryogenesis (right), PRDM14 is expressed and binds upstream of Rnf12. In turn, PRC2 is recruited and methylates H3K27, which leads to Rnf12 repression. Furthermore, Tsix is expressed facilitating PRDM14 binding to Xist intron 1. The lack of Xist activators (Rnf12 and Jpx) and repressive effects of Tsix and PRDM14 on Xist lead to Xist repression, an important step for XCR. A more comprehensive model (Figure S3) includes other key pluripotency factors binding at the Xic implicated in Xist repression (e.g., NANOG, REX1, OCT4, SOX2). Molecular Cell 2013 52, 805-818DOI: (10.1016/j.molcel.2013.10.023) Copyright © 2013 Elsevier Inc. Terms and Conditions